What is BioCryst Pharmaceuticals's total revenue?

BioCryst Pharmaceuticals (BCRX) reported total revenue of $156.41M in Q1 2026.

How has BioCryst Pharmaceuticals's total revenue changed year-over-year?

BioCryst Pharmaceuticals's total revenue increased by 7.5% year-over-year, from $145.53M to $156.41M.

What is the long-term trend for BioCryst Pharmaceuticals's total revenue?

Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's total revenue has grown at a 53.6% compound annual growth rate (CAGR), from $157.17M to $874.84M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

BioCryst Pharmaceuticals BCRX Total Revenue

Total Revenue at other companies

Ionis PharmaceuticalsIONS

$246.09M+87.0%

Ultragenyx PharmaceuticalRARE

$136M-2.2%

BridgeBio PharmaBBIO

$194.52M+66.8%

Arrowhead ResearchARWR

$73.74M-86.4%

ALN

Alnylam PharmaceuticalsALNY

$1.17B+96.4%

Acadia PharmaceuticalsACAD

$268.06M+9.7%

Segments

By segment

See full

Reportable Segment$156.41M+7.5%

Other financials

Income statement

See full

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's total revenue?: BioCryst Pharmaceuticals (BCRX) reported total revenue of $156.41M in Q1 2026.
How has BioCryst Pharmaceuticals's total revenue changed year-over-year?: BioCryst Pharmaceuticals's total revenue increased by 7.5% year-over-year, from $145.53M to $156.41M.
What is the long-term trend for BioCryst Pharmaceuticals's total revenue?: Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's total revenue has grown at a 53.6% compound annual growth rate (CAGR), from $157.17M to $874.84M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.